Cystoid Macular Edema Clinical Trial
Official title:
Incidence and Risk Factors for Cystoid Macular Edema After Primary Vitrectomy With Gas Tamponade for Rhegmatogenous Retinal Detachment: a National Study Group
NCT number | NCT05069675 |
Other study ID # | 69/2021/PO |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | July 12, 2021 |
Est. completion date | January 2023 |
To investigate the incidence of cystoid macular edema in eyes with primary rhegmatogenous retinal detachment successfully treated with vitrectomy with gas tamponade, and to evaluate the clinical variables associated with its development.
Status | Recruiting |
Enrollment | 2000 |
Est. completion date | January 2023 |
Est. primary completion date | October 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - primary rhegmatogenous retinal detachment treated with vitrectomy with gas tamponade; - follow-up of 3 months or more; - age > 18 years ; - no previous eye surgery, except cataract surgery performed at least 6 months after hospitalization for retinal detachment; - anatomical success, i.e. retinal re-attachment, after a single gas vitrectomy; - no other eye surgery during follow-up; - availability of optical coherence tomography (OCT) imaging Exclusion Criteria: - history of other eye diseases (glaucoma, age-related macular degeneration, uveitis, diabetic retinopathy, maculopathy); - macular hole; - recurrent retinal detachment; - use of silicone oil is used as a tamponading agent |
Country | Name | City | State |
---|---|---|---|
Italy | Eye Clinic, University of Bari | Bari | |
Italy | Eye Clinic, Humanitas University | Bergamo | |
Italy | Eye Clinic, Azienda Policlinico San Marco | Catania | |
Italy | Eye Clinic, University of Palermo | Palermo | |
Italy | Eye Clinic, University of Perugia | Perugia | |
Italy | Eye Clinic University of Turin | Turin |
Lead Sponsor | Collaborator |
---|---|
University of Catania |
Italy,
Banker TP, Reilly GS, Jalaj S, Weichel ED. Epiretinal membrane and cystoid macular edema after retinal detachment repair with small-gauge pars plana vitrectomy. Eur J Ophthalmol. 2015 Nov-Dec;25(6):565-70. doi: 10.5301/ejo.5000609. Epub 2015 Apr 15. — View Citation
Chatziralli I, Theodossiadis G, Dimitriou E, Kazantzis D, Theodossiadis P. Macular Edema after Successful Pars Plana Vitrectomy for Rhegmatogenous Retinal Detachment: Factors Affecting Edema Development and Considerations for Treatment. Ocul Immunol Inflamm. 2021 Jan 2;29(1):187-192. doi: 10.1080/09273948.2019.1652330. Epub 2019 Oct 2. — View Citation
Joseph DP, Ryan EH, Ryan CM, Forbes NJK, Wagley S, Yonekawa Y, Mittra RA, Parke DW, Emerson GG, Shah GK, Blinder KJ, Capone A, Williams GA, Eliott D, Gupta OP, Hsu J, Regillo CD. Primary Retinal Detachment Outcomes Study: Pseudophakic Retinal Detachment Outcomes: Primary Retinal Detachment Outcomes Study Report Number 3. Ophthalmology. 2020 Nov;127(11):1507-1514. doi: 10.1016/j.ophtha.2020.05.005. Epub 2020 May 8. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | incidence of cystoid macular edema | cystoid macular edema assessed by OCT (central subfield thickness >310 micron, with presence of intraretinal cystic areas of low reflectivity in OPL) visual acuity | from 1 month up to 6 months after surgery | |
Secondary | factors related to development of macular edema | demographics, systemic and ocular parameters | from 1 month up to 6 months after surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00508040 -
Evaluation of Birdshot Retine Choroidopathy Treatment by Either Steroid or Interferon alpha2a
|
Phase 2 | |
Terminated |
NCT00114062 -
Study to Treat Uveitis Associated Macular Edema
|
Phase 2 | |
Completed |
NCT03025945 -
Prospective Study With Adjunctive Once Daily Topical Nepafenac 0.3% Versus Placebo
|
N/A | |
Completed |
NCT01978015 -
Blood-aqueous Barrier Changes After the Use of Timolol and Prostaglandin Analogues Fixed Combination in Pseudophakic Patients With POAG
|
Phase 4 | |
Recruiting |
NCT05158699 -
Effectiveness of Periocular Drug Injection in CATaract Surgery
|
Phase 3 | |
Withdrawn |
NCT02598869 -
Posterior Subtenon Versus Intravitreal Injection of Triamcinolone Acetonide for Treatment of Uveitic Cystoid Macular Edema
|
Phase 4 | |
Terminated |
NCT04527523 -
Descemet Membrane Endothelial Keratoplasty vs. Descemet's Stripping With Endothelial Keratoplasty vs. Descemet Stripping Only
|
||
Completed |
NCT02294656 -
Acute Pseudophakic Cystoid Macular Edema Treatment Trial: Intravitreal Ranibizumab Versus Triamcinolone Acetonide
|
Phase 1 | |
Withdrawn |
NCT00406172 -
Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME)
|
Phase 3 | |
Not yet recruiting |
NCT04856670 -
Assessing Diabetes Mellitus on Cytokine Analysis and Macular Edema Following FLACS
|
||
Completed |
NCT02609165 -
Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular Edema
|
Phase 2 | |
Withdrawn |
NCT00438243 -
Pilot Study of the Effect of Topical Bromfenac Ophthalmic Solution 0.09%in Patients With Acute Post-operative Cystoid Macular Edema.
|
Phase 2 | |
Completed |
NCT00464581 -
Lucentis for Treatment of Macular Edema
|
N/A | |
Active, not recruiting |
NCT03465124 -
Evaluation of Central Macular Thickness in Femtosecond Laser-assisted Cataract Surgery
|
N/A | |
Recruiting |
NCT02486484 -
Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection
|
Phase 2 | |
Completed |
NCT00790803 -
Pegaptanib Therapy in Non-Infectious Uveitic Cystoid Macular Edema
|
N/A | |
Recruiting |
NCT04225611 -
Therapeutic Contact Lens Drug Delivery System (TCL-DDS) in Patients With Recurrent Cystoid Macular Edema
|
Phase 1/Phase 2 | |
Completed |
NCT05832996 -
Cool vs Room-temperature Artificial Tears
|
Phase 4 | |
Completed |
NCT05615805 -
The Effect of Ocular Rinse Volume on Surface Irritation After Intravitreal Injections
|
N/A | |
Completed |
NCT00494494 -
Effect of Nepafenac on Post-operative Macular Swelling Following Uncomplicated Cataract Surgery
|
Phase 4 |